Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
04 August 2015Website:
http://indaptusrx.comNext earnings report:
14 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Mon, 01 Jul 2024 21:01:49 GMTDividend
Analysts recommendations
Institutional Ownership
INDP Latest News
NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced today that Jeffrey A. Meckler, Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 25th Annual Global Investment Conference. The conference is being held on September 11 – 13, 2023 at the Lotte New York Palace Hotel.
What type of business is Indaptus Therapeutics?
Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B virus and human immunodeficiency virus infection, which is in Phase I clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. was incorporated in 2021 and is headquartered in New York, New York.
What sector is Indaptus Therapeutics in?
Indaptus Therapeutics is in the Healthcare sector
What industry is Indaptus Therapeutics in?
Indaptus Therapeutics is in the Biotechnology industry
What country is Indaptus Therapeutics from?
Indaptus Therapeutics is headquartered in United States
When did Indaptus Therapeutics go public?
Indaptus Therapeutics initial public offering (IPO) was on 04 August 2015
What is Indaptus Therapeutics website?
https://indaptusrx.com
Is Indaptus Therapeutics in the S&P 500?
No, Indaptus Therapeutics is not included in the S&P 500 index
Is Indaptus Therapeutics in the NASDAQ 100?
No, Indaptus Therapeutics is not included in the NASDAQ 100 index
Is Indaptus Therapeutics in the Dow Jones?
No, Indaptus Therapeutics is not included in the Dow Jones index
When does Indaptus Therapeutics report earnings?
The next expected earnings date for Indaptus Therapeutics is 14 August 2024